Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • Blog

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology: Education
Home
An open access peer-reviewed journal in neurologic and neuroscience training
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • Blog

Disclosures

Richard M. Dubinsky, MD, MPH, FAAN

Scientific Advisory Boards
  Allergan Pharmaceuticals, Scientific Advisory board on the treatment of cervical dystonia and chronic daily headache. Head,
Funding for travel or speaker honoraria
  Allergan Pharamceuticals, Irvine, CA, travel and honoraria
Speakers' Bureaus
  Allergan Pharmaceuticals
Research Support, Commercial Entities
  Allergan Pharmaceuticals Auspex Pharmaceuticals, through a sub-contract through the University of Rochester, Site Investigator ENROLL-HD Longitudinal natural history study of Huntington’s disease. B. Landwehrmeyer, PI, Funded by Cure Huntington’s Disease Initiative. 2015–present. Site Investigator NN105
Research Support, Government Entities
  R01NS052592, R01NS052619-01 (Cudkowicz,M, PI) 07/01/08 – 06/30/14 NIAM and NINDS Coenyzme q10 in Huntington's disease (2-CARE) The goal of this project is to determine if high doses of Co Enzyme Q10 can slow the progression of Huntington’s disease Role: site investigator 2007P000827, UO1AT000613 (Hersch,S, PI) 10/01/08 – 09/30/15 NIH/NCCAM and FDA Orphan Products Division Creatine Safety, Tolerability, & Efficacy in Huntington’s disease (CREST-E), The goal of this project is to determine if high doses of creatine can slow the progression of Huntington’s disease Role: site investigator 1R18 HS22004-01 (Narayanaswami, P., PI) 12/1/2012–11/30/15 HHS/AHRQ/PCORI Dissemination of the Clinical Practice Guideline entitled Complementary and Alternative Medicine in Multiple Sclerosis: Comparison of traditional and new innovative techniques This study compares social media dissemination methods to the standard passive dissemination methods for the to be published in fall 2013 AAN practice parameter on complimentary and alternative medications in the treatment of Multiple sclerosis. Role: Co-investigator CERN Grant DR21-05415 October 2015–July 2016 PRE CELL. PI: Vickie Wheelock. Mesenchymal Stem Cells engineered to produce BDNF in HD. Role: Head of Data Safety Monitoring Board NN105 (STAIR) January 2016 – June 2017 PI: Steven Hersch, MD, PhD NN PI. An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity or a Novel Vasopressin la Receptor Antagonist (SRX246) in Irritable Subjects with Huntington's Disease (IID) Azevan Pharmaceuticals Role: Site investigator
Stock/Stock Options/Board of Directors Compensation
  Abbott Labs and Abbvie. Wife owns stock
Neurology: Education: 2 (1)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Education | Online ISSN: 2771-9979

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise